FDA Panel Nixes OTC Singulair | Medpage Today
Montelukast (Singulair) should not be allowed over-the-counter use for hay fever and other upper respiratory allergy symptoms, an FDA advisory panel recommended Friday. The advisors voted 11-to-4 against a risk-benefit ratio supportive of OTC use to treat...